Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Assets (2018 - 2025)

Historic Return on Assets for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.33%.

  • Autolus Therapeutics' Return on Assets changed 0.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.38% for FY2024, which is 1000.0% up from last year.
  • Autolus Therapeutics' Return on Assets amounted to 0.33% in Q3 2025, which was down 0.0% from 0.31% recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Return on Assets registered a high of 0.27% during Q2 2024, and its lowest value of 143.02% during Q3 2021.
  • In the last 5 years, Autolus Therapeutics' Return on Assets had a median value of 0.37% in 2023 and averaged 27.64%.
  • As far as peak fluctuations go, Autolus Therapeutics' Return on Assets plummeted by -1425300bps in 2021, and later surged by 1425700bps in 2022.
  • Autolus Therapeutics' Return on Assets (Quarter) stood at 127.77% in 2021, then surged by 100bps to 0.39% in 2022, then plummeted by -35bps to 0.53% in 2023, then skyrocketed by 49bps to 0.27% in 2024, then dropped by -19bps to 0.33% in 2025.
  • Its Return on Assets stands at 0.33% for Q3 2025, versus 0.31% for Q2 2025 and 0.31% for Q1 2025.